Table 3 Baseline tumor characteristics in the study population
Lymphoma characteristics | No. of patients | |
|---|---|---|
Location | ||
Nodal | Absent | 4 (12.1%) |
Supra | 15 (45.5%) | |
Supra & infra | 14 (42.4%) | |
Extra-nodal | Absent | 16 (48.5%) |
Splenic | 7 (21.2%) | |
Oropharyngeal | 2 (6.1%) | |
Splenic & hepatic | 1 (3.0%) | |
Hepatic & renal | 1 (3.0%) | |
Gastric & hepatic | 1 (3.0%) | |
Splenic & renal | 1 (3.0%) | |
Parapharyngeal | 1 (3.0%) | |
Parotid | 1 (3.0%) | |
Lung | 1 (3.0%) | |
Bone | 1 (3.0%) | |
Stage | I | 2 (6.1%) |
IE | 1 (3.0%) | |
II | 11 (33.3%) | |
IIE | 1 (3.0%) | |
III | 5 (15.2%) | |
IIIS | 7 (21.2%) | |
IV | 6 (18.2%) | |